结核性胸腔积液三种不同治疗方式近期疗效观察

中国防痨杂志 ›› 2005, Vol. 27 ›› Issue (5): 322-324.

结核性胸腔积液三种不同治疗方式近期疗效观察

尚好珍；姚恒波；郭磊；来中海；冯菊梅；王永亮；张斌；

河南省新乡医院第一附属医院结核病研究所卫辉 453100；

出版日期:2005-05-10 发布日期:2005-11-03

Study on the three different treatment means of tuberculosis pleurisy

Shang Haozhen,Yao Hengbo,Guo Lei,et al.

The Tuberculosis Research Institute of XingXiang Medical College,WeiHui 453100,Chian

Online:2005-05-10 Published:2005-11-03

摘要/Abstract

摘要： 目的　探讨结核性渗出性胸腔积液治疗方式。方法 123例中等量以上积液的结核性胸膜炎病人作为研究对象。患者按入院先后顺序随机分为3组。A组42例,胸腔置管引流并胸腔内注射微卡(母牛分枝杆菌菌苗);B组45例,单纯置管引流;C组36例,常规胸腔穿刺抽液每周1～2次。3组患者的化疗方案均为2HRZE(S)/4HR。C组口服强的松30mg/d。治疗1个月检查。结果 1个月A组胸液控制率95.3%,显效36例(85.7%),有效4例(9.6%),无效2例(4.7%),6个月总有效率100%;B组胸液控制率91.1%,显效36例(80%),有效5例(11.1%),无效4例(8.9%),6个月总有效率100%;C组胸液控制率66.6%,显效3例(8.3%),有效21例(58.3%),无效12例(33.3%),6个月总有效率83.3%。结论深静脉导管引流胸腔积液,注药与不注药无显著性差异,但明显优于常规胸穿抽液。

关键词: 结核,胸膜, 胸腔积液, 引流术

Abstract: Objective To probe the treatment means of tuberculosis pleural effusion.Method 123 received creating cases of tuberculosis pleurisy were divided into group A,B,and C at random,group A:42 cases put drainage in the thorax and inject Vaccae in it,group B: 45cases put drainage in the thorax only,group C:36cases,carry aspiration for pleural effusion one or two times of a week.Three groups all use 2HRZE/4HR,and group C use Pedisorn 30?mg/d.Results After one month treating,the group A controlling rate is 95.3%,36(85.7%)have remarkable result,4(9.6%) have effective result,2(4.7%) have no effective,have effective result 100% after 6 months;The group B,controlling rate is 91.1%,36(80%)have remarkable result,5(11.1%) have effective result,4(8.9%) have no effective,have effective result 100% after 6 months;Group C: controlling rate is 66.6%,3(8.3%)have remarkable result,21(58.3%)have effective result,12(33.3%) have no effective,have effective result 83.3% after 6 months.Conclusion There have no remarkable difference of inject drug or no when put drainage in the thorax.

Key words: Tuberculosis pleural, Pleural effusion, Drainage

尚好珍,姚恒波,郭磊,来中海,冯菊梅,王永亮,张斌,. 结核性胸腔积液三种不同治疗方式近期疗效观察[J]. 中国防痨杂志, 2005, 27(5): 322-324.

Shang Haozhen,Yao Hengbo,Guo Lei,et al.. Study on the three different treatment means of tuberculosis pleurisy[J]. Chinese Journal of Antituberculosis, 2005, 27(5): 322-324.

[1]	刘琳. 35例妊娠期结核性胸膜炎患者临床诊疗结果分析[J]. 中国防痨杂志, 2020, 42(7): 731-736.
[2]	朱建坤, 孟倩, 金锋. 脂氧素A4在结核性胸膜纤维化中的表达水平及影响机制初探[J]. 中国防痨杂志, 2020, 42(5): 489-492.
[3]	孟素华. GeneXpert MTB/RIF检测技术在结核性胸膜炎诊断中的应用价值[J]. 中国防痨杂志, 2019, 41(9): 1005-1008.
[4]	孙逸敏,王振清,贾佳,谷化平. 液基细胞学技术在肺结核诊断中的应用价值[J]. 中国防痨杂志, 2019, 41(8): 882-886.
[5]	刘思源,窦吉辰,饶涛,赵衡,高康,周奕,李锦峰,郑刚,寸新华. 术前穿刺置管冲洗引流联合手术治疗复发性脊柱结核的效果分析[J]. 中国防痨杂志, 2019, 41(4): 457-462.
[6]	冯军鹏,李义帅,秦学博,李建行,李玉琢,魏兰. 胸腔冲洗在结核性支气管胸膜瘘术前治疗中的价值(附68例报告)[J]. 中国防痨杂志, 2019, 41(4): 466-468.
[7]	贾晨光,马辉,王连波,姚黎明,李卓,刘丰胜,董昭良. 局部病灶清除置管冲洗引流术治疗胸腰椎结核患者术后脓肿并发症的疗效分析[J]. 中国防痨杂志, 2019, 41(3): 272-276.
[8]	吴迪,林友飞,陈晓红,沈建山,陈效友. 白介素27和腺苷脱氢酶单独及联合检测对结核性胸膜炎诊断价值[J]. 中国防痨杂志, 2019, 41(12): 1246-1251.
[9]	孙卉,许红兰,刘晓玲. 自制引流管贴膜在结核性胸膜炎置管护理中的应用观察[J]. 中国防痨杂志, 2018, 40(6): 649-651.
[10]	刘丰胜,贾晨光,李卓,姚黎明,姚晓伟,刘威,王连波,董昭良. 一期病灶清除植骨内固定联合置管冲洗治疗原发性胸腰椎非特异性感染[J]. 中国防痨杂志, 2018, 40(5): 479-484.
[11]	王桂荣,王淑琦,姜广路,黄麦玲,杨新婷,陈效友,黄海荣. 不同技术联合检测痰液和胸腔积液对结核性胸膜炎的诊断价值[J]. 中国防痨杂志, 2018, 40(4): 365-371.
[12]	杨磊,张金贵,金锋. 负压封闭引流技术在淋巴结结核治疗中的应用[J]. 中国防痨杂志, 2018, 40(12): 1271-1274.
[13]	刘浩然,张亚莉,任卫聪,赵玲娟,李传友,王伟,高孟秋. 三种细胞因子在肺结核与肺癌胸腔积液中的诊断价值[J]. 中国防痨杂志, 2018, 40(10): 1046-1050.
[14]	陈玲,卢利红,孙君红. 尿激酶联合臭氧序贯冲洗辅助治疗结核性包裹性胸腔积液的临床效果[J]. 中国防痨杂志, 2018, 40(10): 1095-1098.
[15]	廖鲁燕,赵明伟,杨国峰. RNA恒温扩增实时荧光检测技术对结核性胸腔积液的诊断价值[J]. 中国防痨杂志, 2018, 40(1): 84-86.